Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 5363-5372

  Koziel, Joanna ^a   Bryzek, Danuta ^a   Sroka, Aneta ^a   Maresz, Katarzyna ^a   Glowczyk, Izabela ^a   Bielecka, Ewa ^a   Kantyka, Tomasz ^a   Pyrć, Krzysztof ^a   Svoboda, Pavel ^b   Pohl, Jan ^b   Potempa, Jan ^a,c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; ENDOTOXIN; GALACTOSAMINE; INTERLEUKIN 6; LIPOTEICHOIC ACID; LYSINE; PROTEIN ARGININE DEIMINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTOXIN INDUCED SEPSIS; ENZYME RELEASE; HOST RESISTANCE; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PURIFICATION; SEPSIS; SEPTIC SHOCK;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CITRULLINE; FEMALE; HUMANS; HYDROLASES; IMMUNITY, INNATE; INTERFERON INDUCERS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; POLY I-C; SEPSIS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84901268042     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303062     Document Type: Article

References (40)

1. Choi, K. Y., L. N. Chow, and N. Mookherjee. 2012. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. J. Innate Immun. 4: 361-370.
2. Durr, U. H., U. S. Sudheendra, and A. Ramamoorthy. 2006. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 1758: 1408-1425.
3. Sørensen, O., K. Arnljots, J. B. Cowland, D. F. Bainton, and N. Borregaard. 1997. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90: 2796-2803.
4. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krö tz, S. Zahler, T. Gloe, K. Issbrucker, P. Unterberger, M. Zaiou, C. Lebherz, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111: 1665-1672.
5. Travis, S. M., N. N. Anderson, W. R. Forsyth, C. Espiritu, B. D. Conway, E. P. Greenberg, P. B. McCray, Jr., R. I. Lehrer, M. J. Welsh, and B. F. Tack. 2000. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 68: 2748-2755.
6. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169: 3883-3891.
7. Niyonsaba, F., K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106: 20-26.
8. Heilborn, J. D., M. F. Nilsson, G. Kratz, G. Weber, O. Sørensen, N. Borregaard, and M. Stahle-Bäckdahl. 2003. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120: 379-389.
9. Mookherjee, N., K. L. Brown, D. M. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F. M. Roche, R. Mu, G. H. Doho, J. Pistolic, et al. 2006. Modulation of the TLRmediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176: 2455-2464.
10. Johansson, J., G. H. Gudmundsson, M. E. Rottenberg, K. D. Berndt, and B. Agerberth. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273: 3718-3724.
11. Oren, Z., J. C. Lerman, G. H. Gudmundsson, B. Agerberth, and Y. Shai. 1999. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341: 501-513.
12. Nagaoka, I., S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, H. Tamura, and D. Heumann. 2001. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J. Immunol. 167: 3329-3338.
13. Cirioni, O., A. Giacometti, R. Ghiselli, C. Bergnach, F. Orlando, C. Silvestri, F. Mocchegiani, A. Licci, B. Skerlavaj, M. Rocchi, et al. 2006. LL-37 protects rats against lethal sepsis caused by Gram-negative bacteria. Antimicrob. Agents Chemother. 50: 1672-1679.
14. Dathe, M., and T. Wieprecht. 1999. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1462: 71-87.
15. Rosenfeld, Y., N. Lev, and Y. Shai. 2010. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides. Biochemistry 49: 853-861.
16. György, B., E. Tóth, E. Tarcsa, A. Falus, and E. I. Buzás. 2006. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 38: 1662-1677.
17. Vossenaar, E. R., A. J. Zendman, W. J. van Venrooij, and G. J. Pruijn. 2003. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25: 1106-1118.
18. Vossenaar, E. R., T. R. Radstake, A. van der Heijden, M. A. van Mansum, C. Dieteren, D. J. de Rooij, P. Barrera, A. J. Zendman, and W. J. van Venrooij. 2004. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 63: 373-381.
19. Nachat, R., M. C. Méchin, H. Takahara, S. Chavanas, M. Charveron, G. Serre, and M. Simon. 2005. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J. Invest. Dermatol. 124: 384-393.
20. Ishigami, A., T. Ohsawa, H. Asaga, K. Akiyama, M. Kuramoto, and N. Maruyama. 2002. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. Arch. Biochem. Biophys. 407: 25-31.
21. Méchin, M. C., M. Sebbag, J. Arnaud, R. Nachat, C. Foulquier, V. Adoue, F. Coudane, H. Duplan, A. M. Schmitt, S. Chavanas, et al. 2007. Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. Int. J. Cosmet. Sci. 29: 147-168.
22. Foulquier, C., M. Sebbag, C. Clavel, S. Chapuy-Regaud, R. Al Badine, M. C. Méchin, C. Vincent, R. Nachat, M. Yamada, H. Takahara, et al. 2007. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56: 3541-3553.
23. Loos, T., A. Mortier, M. Gouwy, I. Ronsse, W. Put, J. P. Lenaerts, J. Van Damme, and P. Proost. 2008. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. Blood 112: 2648-2656.
24. Proost, P., T. Loos, A. Mortier, E. Schutyser, M. Gouwy, S. Noppen, C. Dillen, I. Ronsse, R. Conings, S. Struyf, et al. 2008. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J. Exp. Med. 205: 2085-2097.
25. Kilsgard, O., P. Andersson, M. Malmsten, S. L. Nordin, H. M. Linge, M. Eliasson, E. Sörenson, J. S. Erjefält, J. Bylund, A. I. Olin, et al. 2012. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Am. J. Respir. Cell Mol. Biol. 46: 240-248.
26. Barlow, P. G., P. Svoboda, A. Mackellar, A. A. Nash, I. A. York, J. Pohl, D. J. Davidson, and R. O. Donis. 2011. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 6: e25333.
27. Bzowska, M., M. Hamczyk, A. Skalniak, and K. Guzik. 2011. Rapid decrease of CD16 (FcgRIII) expression on heat-shocked neutrophils and their recognition by macrophages. J. Biomed. Biotechnol. 2011: 284759.
28. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76: 5939-5943.
29. Boyde, T. R., and M. Rahmatullah. 1980. Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal. Biochem. 107: 424-431.
30. Nijnik, A., J. Pistolic, A. Wyatt, S. Tam, and R. E. Hancock. 2009. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. J. Immunol. 183: 5788-5798.
31. Blazusiak, E., D. Florczyk, J. Jura, J. Potempa, and J. Koziel. 2013. Differential regulation by Toll-like receptor agonists reveals that MCPIP1 is the potent regulator of innate immunity in bacterial and viral infections. J. Innate Immun. 5: 15-23.
32. Kandler, K., R. Shaykhiev, P. Kleemann, F. Klescz, M. Lohoff, C. Vogelmeier, and R. Bals. 2006. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int. Immunol. 18: 1729-1736.
33. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y. Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176: 231-241.
34. Wang, Y., M. Li, S. Stadler, S. Correll, P. Li, D. Wang, R. Hayama, L. Leonelli, H. Han, S. A. Grigoryev, et al. 2009. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184: 205-213.
35. Villanueva, E., S. Yalavarthi, C. C. Berthier, J. B. Hodgin, R. Khandpur, A.M. Lin, C. J. Rubin,W. Zhao, S. H. Olsen, M. Klinker, et al. 2011. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187: 538-552.
36. McDonald, B., R. Urrutia, B. G. Yipp, C. N. Jenne, and P. Kubes. 2012. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12: 324-333.
37. Berkestedt, I., A. Nelson, and M. Bodelsson. 2008. Endogenous antimicrobial peptide LL-37 induces human vasodilatation. Br. J. Anaesth. 100: 803-809.
38. Rintala, E., H. Peuravuori, K. Pulkki, L. M. Voipio-Pulkki, and T. Nevalainen. 2000. Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome. Intensive Care Med. 26: 1248-1251.
39. Berkestedt, I., H. Herwald, L. Ljunggren, A. Nelson, and M. Bodelsson. 2010. Elevated plasma levels of antimicrobial polypeptides in patients with severe sepsis. J. Innate Immun. 2: 478-482.
40. Into, T., M. Inomata, K. Shibata, and Y. Murakami. 2010. Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts. Cell. Immunol. 264: 104-109.